Profil
Marc Bonneville is the founder of Innate Pharma SA, which was founded in 1999.
He is currently the Director at Global Virus Network and Vice President-Medical & Scientific Affairs at Institut Mérieux SA since 2013.
Dr. Bonneville's former positions include Research Director at Centre National de la Recherche Scientifique, Director at Platine Pharma Services SAS, and Independent Director at GeNeuro SA (Switzerland) from 2015 to 2020.
Dr. Bonneville holds a doctorate degree from Massachusetts Institute of Technology.
Postes actifs de Marc Bonneville
| Sociétés | Poste | Début |
|---|---|---|
Institut Mérieux SA
Institut Mérieux SA BiotechnologyHealth Technology Provides solutions for multifactorial management of diseases | Directeur Technique/Scientifique/R&D | 01/01/2013 |
Global Virus Network
Global Virus Network Miscellaneous Commercial ServicesCommercial Services Researches on essential and critical defense against viral disease | Directeur/Membre du Conseil | - |
Anciens postes connus de Marc Bonneville
| Sociétés | Poste | Fin |
|---|---|---|
| GENEURO SA | Directeur/Membre du Conseil | 25/09/2020 |
Centre National de la Recherche Scientifique
Centre National de la Recherche Scientifique General GovernmentGovernment Provides scientific research services | Corporate Officer/Principal | 01/01/2013 |
Platine Pharma Services SAS
Platine Pharma Services SAS Medical/Nursing ServicesHealth Services Provides immune-monitoring services | Directeur/Membre du Conseil | - |
| INNATE PHARMA | Fondateur | - |
Formation de Marc Bonneville
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Innate Pharma SA
Innate Pharma SA Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies that harness the immune system to improve cancer treatment and clinical outcomes | Health Technology |
Centre National de la Recherche Scientifique
Centre National de la Recherche Scientifique General GovernmentGovernment Provides scientific research services | Government |
Institut Mérieux SA
Institut Mérieux SA BiotechnologyHealth Technology Provides solutions for multifactorial management of diseases | Health Technology |
Platine Pharma Services SAS
Platine Pharma Services SAS Medical/Nursing ServicesHealth Services Provides immune-monitoring services | Health Services |
Global Virus Network
Global Virus Network Miscellaneous Commercial ServicesCommercial Services Researches on essential and critical defense against viral disease | Commercial Services |
GeNeuro SA (Switzerland)
GeNeuro SA (Switzerland) BiotechnologyHealth Technology Engages in the research and development of pharmaceutical products to treat neurological diseases | Health Technology |
















